Galapagos | GLPG - Cost Of Sales

Stock Price
28.18
Daily Change
-0.42 -1.47%
Monthly
0.50%
Yearly
27.63%
Q1 Forecast
27.75

Galapagos reported EUR84.73M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
argenx SE USD 109.43M 1.32M Sep/2025
AstraZeneca USD 2.8B 328M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Genmab DKK 57M 15M Jun/2025
Gilead Sciences USD 1.57B 68M Sep/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Incyte USD 99M 20.23M Sep/2025
Merck EUR 2.1B 123M Sep/2025
Neurocrine Biosciences USD 264M 252.7M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
UCB EUR 901M 50M Dec/2024
Vertex Pharmaceuticals USD 414.8M 7.3M Sep/2025